KMTS Company Profile and Key Details

NASDAQ : KMTS

KESTRA MEDICAL TECHNOLOGIES LTD

$24.43

-2.22-8.33%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) stock declined over -8.33%, trading at $24.43 on NASDAQ, down from the previous close of $26.65. The stock opened at $26.82, fluctuating between $24.03 and $27.55 in the recent session.

Stock Snapshot

26.65

Prev. Close

1.43B

Market Cap

24.03

Day Low

-6.17

P/E Ratio

-3.96

EPS (TTM)

N/A

Cash Flow per Share

26.82

Open

58.35M

Number of Shares

27.5542

Day High

46.53%

Free Float in %

N/A

Book Value

283.62K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 09, 2026	26.82	27.55	24.03	24.43	283.44K
Jan 08, 2026	26.42	27.20	26.00	26.65	171.54K
Jan 07, 2026	25.66	26.95	25.30	26.61	144.91K
Jan 06, 2026	24.46	25.62	23.87	25.54	323.31K
Jan 05, 2026	24.34	25.14	24.27	24.42	312.34K
Jan 02, 2026	26.43	27.07	24.01	24.39	462.46K
Dec 31, 2025	27.02	27.61	26.27	26.52	489.94K
Dec 30, 2025	26.46	27.00	26.10	26.97	176.99K
Dec 29, 2025	26.76	27.03	26.36	26.43	186.85K
Dec 26, 2025	27.44	27.49	26.63	27.13	106.46K
Dec 24, 2025	27.65	27.96	26.90	27.52	91.05K
Dec 23, 2025	27.97	28.40	27.14	27.55	260.33K
Dec 22, 2025	27.38	28.84	26.72	28.01	340.86K
Dec 19, 2025	27.17	27.82	26.67	27.32	804.05K
Dec 17, 2025	26.98	27.63	26.49	26.82	284.21K
Dec 16, 2025	26.42	27.60	26.42	27.00	455.16K
Dec 15, 2025	26.15	27.33	25.63	26.48	366.04K
Dec 12, 2025	26.45	27.18	24.32	26.17	400.17K
Dec 11, 2025	24.63	25.53	24.52	24.91	332.75K
Dec 10, 2025	24.52	25.19	23.46	24.52	299.26K

Contact Details

Kirkland, WA 98033

United States

https://kestramedical.com 425 279 8002

About Company

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Stock Peers

ISRG

1.16+0.20%

Intuitive Surgical, Inc.$586.24 ATRI

0.26+0.06%

Atrion Corporation$459.92 RGEN

0.4+0.24%

Repligen Corporation$166.82 ICUI

1.34+0.88%

ICU Medical, Inc.$152.99 MASI

1.01+0.73%

Masimo Corporation$138.92 MMSI

-6.8-7.30%

Merit Medical Systems, Inc.$86.38 LMAT

-0.04-0.05%

LeMaitre Vascular, Inc.$85.00 COO

0.32+0.38%

The Cooper Companies, Inc.$83.45 HOLX

-0.01-0.01%

Hologic, Inc.$74.87 UTMD

1.175+2.00%

Utah Medical Products, Inc.$59.90

Company Overview

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) closed at $24.43 USD, losing -$2.22 (-8.33%) from the previous close of $26.65. The stock is currently mid-range between its 52-week high and low $13.25 and $30.00. With a market capitalization of about $1.43 billion, KESTRA MEDICAL TECHNOLOGIES, LTD. is classified as a small-cap and shows lower-than-market volatility (beta ~-0.41). Key stats such as the average daily volume over the past year has been around 322.61 thousand shares, in line with its 52-week average. Headquartered in Kirkland, WA, KESTRA MEDICAL TECHNOLOGIES, LTD. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Brian Webster, the company employs approximately 300 people and listed since March 06, 2025. Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -7.46%, SMA50 -6.44%, SMA200 11.19%). The stock’s 14-day RSI is 41.99 (neutral), while the ATR of 1.7 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.57% below its high and over 84.38% above its low. Average 10-day trading volume of 283.00 thousand shares is in line with the 3-month average of 311.86 thousand, indicating normal recent market interest.

Valuation Metrics

KESTRA MEDICAL TECHNOLOGIES, LTD. trades at a P/E ratio of -9.5, slightly below the S&P 500 average, with a price-to-sales ratio of 19.2 and a price-to-book ratio of 7.65 trading at moderately above to book value. The P/FCF stands at -12.48, also above market averages.

Dividend & Fair Value

KESTRA MEDICAL TECHNOLOGIES, LTD. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$22.50. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 31.93% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 2 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $32.00 to $24.00. The high target offers 30.99% upside. The low target suggests -1.76% downside. The mean target is $27.80. This offers 13.79% upside. KESTRA MEDICAL TECHNOLOGIES, LTD. earnings surprise history is a mixed track record. The quarter that ended December 11, 2025, missed forecasts by 10.71%. The prior quarter beat by -30.3%. Over the last six quarters, Apple has recorded several small beats. These include -30.3% in September 11, 2025.

Shareholding & Insider Activity

KESTRA MEDICAL TECHNOLOGIES, LTD. has 51.35 million shares outstanding. The public float is 3.98 million shares, elevated short interest at 8.68% of float. This equals 2.07 million shares. The short ratio is 5.01 days. Institutional investors hold 100.78% of the float. Insiders own 6.44%. Webster Brian Daniel holds 409.79 thousand shares, Umberger Traci S has 136.63 thousand shares and Ford Alfred J Jr has 49.41 thousand shares. Over the past six months, insider transactions show net selling. They sold 25.50 thousand shares across 2 transactions.

Financial & Profitability Overview

Over the trailing twelve months, KESTRA MEDICAL TECHNOLOGIES LTD generated $59.82M in revenue, or $1.21 per share. Gross margin was 40.47%, operating margin -177.85%, and net profit margin -190.28%. Returns are negative, with ROA at -38.48% and ROE at -55.41%.
On valuation metrics, KESTRA MEDICAL TECHNOLOGIES LTD trades at a P/E of -9.50, P/S of 19.20 and P/B of 7.65. The current ratio is 5.47 and quick ratio is 5.47. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -134.13 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.02, supported by a cash flow-to-debt ratio of -29.62.

Quarterly Financial Highlights

Gross profit was $24.21M (margin 40.47%). Operating income was - $106.38M (margin -177.8%). Net income was- $113.81M (EPS - $5.13).
The company ended the quarter with $237.60M in cash and short-term investments, a total debt of $44.31M, and net debt of - $193.28M. Total assets were $295.74M, with equity of $205.41M. Financials further reflected weakness, with operating cash flow of - $77.61M, free cash flow of - $101.20M, and capital expenditures of - $23.59M.

Price Forecast & Outlook

Our AI price prediction model suggests that KESTRA MEDICAL TECHNOLOGIES, LTD. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 6.1%, with price expected at $25.92 by January 23, 2026, within a range of $24.45 to $27.34 3-Month Outlook: Projected rise of 13.14%, reaching $27.64 by April 09, 2026, with a range of $27.23 to $28.08. 1-Year Outlook: Projected gain of 61.6%, with price at $39.48 by December 31, 2026, within a range of $37.97 to $40.83.

Key Takeaways

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) shares are flat 0.49% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows KESTRA MEDICAL TECHNOLOGIES, LTD. trading at a premium to the broader market with a P/E of -9.5. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $27.80, suggesting 13.79% upside. Our AI forecast model points to short-term strength (6.1% over two weeks), a medium-term rise (13.14% over three months), and a longer-term gain (61.6% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) stock price?

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ: KMTS) stock price is $24.43 in the last trading session. During the trading session, KMTS stock reached the peak price of $27.55 while $24.03 was the lowest point it dropped to. The percentage change in KMTS stock occurred in the recent session was -8.33% while the dollar amount for the price change in KMTS stock was - $2.22.

KMTS's industry and sector of operation?

The NASDAQ listed KMTS is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. KESTRA MEDICAL TECHNOLOGIES, LTD. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KMTS?

No Data

How KMTS did perform over past 52-week?

KMTS's closing price is 84.38% higher than its 52-week low of $13.25 where as its distance from 52-week high of $30.00 is -18.57%.

How many employees does KMTS have?

Number of KMTS employees currently stands at 300.

Link for KMTS official website?

Official Website of KMTS is: https://kestramedical.com

How do I contact KMTS?

KMTS could be contacted at phone 425 279 8002 and can also be accessed through its website. KMTS operates from 3933 Lake Washington Blvd NE, Kirkland, WA 98033, United States.

How many shares of KMTS are traded daily?

KMTS stock volume for the day was 283.62K shares. The average number of KMTS shares traded daily for last 3 months was 322.61K.

What is the market cap of KMTS currently?

The market value of KMTS currently stands at $1.43B with its latest stock price at $24.43 and 58.35M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	300
Beta	-0.41
Sales or Revenue	$59.82M
5Y Sales Change%	0%
Fiscal Year Ends	April
Sector	Healthcare
Industry	Medical - Instruments & Supplies

KMTS Company Profile and Key Details

KESTRA MEDICAL TECHNOLOGIES LTD

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Earnings & Analyst Outlook

Key Takeaways

Price Forecast & Outlook

Valuation Metrics